CSI Market
Sign In | Register

180 Life Sciences (ATNF) Annual Balance Sheets

Annual · GAAP · USD millions
Access ATNF quarterly Balance Sheets →
Tracking balance sheet results across 180 Life Sciences to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent8.02
Marketable Securities4.41
Cash & Short-term Investments12.00
Other Receivables0.00
Notes, Loans and Financing Receivable, Net, Current AC0.00
Disposal Group, Including Discontinued Operation, Assets, Current AS0.02
Income Taxes, Current0.00
Prepaid Expense And Other Assets Current7.73
Total Current Assets0.00
Goodwill net0.00
Intangible Assets0.00
Long-term investments5.43
Interest Receivable, Noncurrent181.01
Tax Assets, Noncurrent0.64
Other Assets, Noncurrent0.00
Inprocess Research And Development-
Total Assets306.30
Liabilities
Accounts Payable1.54
Accrued Liabilities, Current AC6.38
Collateralized Financings LI131.51
Loans Payable, Current NO0.25
Other Liabilities, Current0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI1.23
Total Current Liabilities40.91
Long-term debt57.71
Total Long-term Debt57.71
Accrued Income Taxes, Noncurrent0.64
Discontinued Operation, Noncurrent1.23
Other liabilities, Noncurrent0.00
DeferredIncomeTaxLiabilitiesNet-
Operating Lease Liability Current-
Loans Payable Related Parties-
Convertible Notes Payable Related Parties Current-
Total Liabilities66.88
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock834.45
Retained Earnings / Accumulated Deficit-592.04
Accumulated Other Comprehensive Income-2.99
Other Equity-2.99
Common Stockholder's Equity222.12
Preferred Stockholder's Equity0.00
Non-controlling interests & other17.30
Total Stockholder's Equity239.42
Liabilities & Stockholder's Equity306.30
4 historic quarters locked

Sign in to unlock the full 180 Life Sciences balance sheet history.

Sign In Create Free Account

About Forum Markets Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-037888

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.